Literature DB >> 7003867

Enzyme-linked immunosorbent assay (ELISA): a study of antibodies to Mycobacterium tuberculosis in the IgG, IgA and IgM classes in tuberculosis, sarcoidosis and Crohn's disease.

J M Grange, J Gibson, E Nassau, T Kardjito.   

Abstract

Enzyme-linked immunosorbent assay (ELISA) has been used to study the levels of antibody binding to the soluble antigens of Mycobacterium tuberculosis (BCG) in the IgG, IgM and IgA classes in sera from patients with tuberculosis, sarcoidosis and Crohn's disease. Of the patients with tuberculosis, 75% had significantly elevated levels of anti-M. tuberculosis antibodies in the IgG class. The levels of antibodies in the IgM and IgA classes were much less discriminative. Many of the patients with sarcoidosis and Crohn's disease had significantly elevated levels of antimycobacterial antibodies, principally in the IgM and IgA classes. These elevated levels of antibody were not related to the total levels of the immunoglobulin classes. For the purpose of serodiagnosis, an estimation of the antimycobacterial antibodies in the IgG class gives the most discriminative results.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7003867     DOI: 10.1016/0041-3879(80)90003-3

Source DB:  PubMed          Journal:  Tubercle        ISSN: 0041-3879


  28 in total

1.  Immunoglobulin A (IgA) and IgG serum antibodies to mycobacterial antigens in Crohn's disease patients and their relatives.

Authors:  L G Wayne; D Hollander; B Anderson; H A Sramek; C M Vadheim; J I Rotter
Journal:  J Clin Microbiol       Date:  1992-08       Impact factor: 5.948

2.  Serodiagnostic tests for tuberculosis: a need for assessment of their operational predictive accuracy and acceptability.

Authors:  J M Grange; A Laszlo
Journal:  Bull World Health Organ       Date:  1990       Impact factor: 9.408

3.  Effect of intestinal resection on serum antibodies to the mycobacterial 45/48 kilodalton doublet antigen in Crohn's disease.

Authors:  G Kreuzpaintner; P K Das; A Stronkhorst; A W Slob; G Strohmeyer
Journal:  Gut       Date:  1995-09       Impact factor: 23.059

4.  Enzyme immunoassay using BCG in serodiagnosis of pulmonary tuberculosis.

Authors:  F L Garcia-Carreño; R E Carvajal; R Hernandez
Journal:  J Hyg (Lond)       Date:  1986-12

5.  Antibody responses of cervids (Cervus elaphus) following experimental Mycobacterium bovis infection and the implications for immunodiagnosis.

Authors:  Noel P Harrington; Om P Surujballi; John F Prescott; J Robert Duncan; W Ray Waters; Konstantin Lyashchenko; Rena Greenwald
Journal:  Clin Vaccine Immunol       Date:  2008-09-24

6.  Mycobacterial aetiology of Crohn's disease: serologic study using common mycobacterial antigens and a species-specific glycolipid antigen from Mycobacterium paratuberculosis.

Authors:  S N Cho; P J Brennan; H H Yoshimura; B I Korelitz; D Y Graham
Journal:  Gut       Date:  1986-11       Impact factor: 23.059

7.  Serodiagnosis of pulmonary tuberculosis in Argentina by enzyme-linked immunosorbent assay (ELISA) of IgG antibody to Mycobacterium tuberculosis antigen 5 and tuberculin purified protein derivative.

Authors:  E A Balestrino; T M Daniel; M D de Latini; O A Latini; Y Ma; J B Scocozza
Journal:  Bull World Health Organ       Date:  1984       Impact factor: 9.408

8.  Possible role of mycobacteria in inflammatory bowel disease. II. Mycobacterial antibodies in Crohn's disease.

Authors:  W R Thayer; J A Coutu; R J Chiodini; H J Van Kruiningen; R S Merkal
Journal:  Dig Dis Sci       Date:  1984-12       Impact factor: 3.199

9.  Characterization, sequence determination, and immunogenicity of a 64-kilodalton protein of Mycobacterium bovis BCG expressed in escherichia coli K-12.

Authors:  J E Thole; W J Keulen; J De Bruyn; A H Kolk; D G Groothuis; L G Berwald; R H Tiesjema; J D van Embden
Journal:  Infect Immun       Date:  1987-06       Impact factor: 3.441

10.  Investigations on etiology of Crohn's disease. Humoral immune response to stress (heat shock) proteins.

Authors:  D C Markesich; E T Sawai; J S Butel; D Y Graham
Journal:  Dig Dis Sci       Date:  1991-04       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.